問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Shin Kong Memorial Wu Ho-Su Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Neurology
下載
2025-02-01 - 2027-12-31
Condition/Disease
● Evaluate the safety and tolerability of DNTH103 in patients with generalized myasthenia gravis (gMG) up to week 13.
Test Drug
DNTH103 150 mg/mL
Participate Sites8Sites
Recruiting8Sites
2010-10-01 - 2012-12-31
Participate Sites5Sites
Terminated5Sites
2010-04-01 - 2012-04-30
2022-06-01 - 2027-10-31
Participate Sites7Sites
Not yet recruiting7Sites
2021-01-01 - 2029-07-31
2009-08-01 - 2012-12-31
Participate Sites6Sites
Terminated6Sites
2021-11-01 - 2028-11-11
Recruiting5Sites
2009-12-01 - 2014-01-31
2024-11-01 - 2029-08-31
Participate Sites2Sites
Not yet recruiting1Sites
Recruiting1Sites
2023-01-01 - 2027-12-31
Recruiting4Sites
全部
